(UroToday.com) Professor James Catto discussed the safe and optimal management of muscle-invasive bladder cancer (MIBC) in the time of COVID-19 pandemic at the European Association of Urology (EAU) 2021 virtual annual meeting’s plenary session on advanced bladder cancer. Based on data from the COVID-19 dashboard at Johns Hopkins University from June 15, 2021, the COVID-19 pandemic has globally resulted in more than 176 million cases, more than 3.8 million deaths, and more than 2.3 billion vaccine doses administered.